BCM
CNTB

BML Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

BML Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Hold
408,887
– – 0.69% 14
2025
Q4 		$1.15M Sell
408,887
-858,613
-68% -$1.83M 1% 13
2025
Q3 		$1.91M Sell
1,267,500
-554,058
-30% -$981K 1.75% 10
2025
Q2 		$1.79M Sell
1,821,558
-271,674
-13% -$217K 1.35% 15
2025
Q1 		$1.15M Hold
2,093,232
– – 0.93% 16
2024
Q4 		$2.89M Hold
2,093,232
– – 1.79% 13
2024
Q3 		$3.01M Buy
2,093,232
+49,984
+2% +$61K 1.77% 13
2024
Q2 		$3.11M Sell
2,043,248
-18,090
-0.9% -$29.7K 2.22% 11
2024
Q1 		$3.59M Sell
2,061,338
-100
-0% -$122 2.37% 11
2023
Q4 		$2.43M Buy
+2,061,438
New +$2.45M 1.84% 14

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BML Capital Management's CNTB Position: Q1 2026 in Review

BML Capital Management held its Connect Biopharma Holdings (CNTB) position steady in Q1 2026 at 408,887 shares worth $1.07M. The position accounts for 0.69% of the portfolio, ranked #14.

BML Capital Management first reported a position in CNTB in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.59M in Q1 2024. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • BML Capital Management held 408,887 shares of Connect Biopharma Holdings worth $1.07M as of Q1 2026.
  • BML Capital Management left its Connect Biopharma Holdings share count unchanged in Q1 2026.
  • Connect Biopharma Holdings made up 0.69% of BML Capital Management's portfolio in Q1 2026, its #14 holding.
  • BML Capital Management first reported a position in Connect Biopharma Holdings in Q4 2023 and has held it in 10 quarters since.
  • BML Capital Management's Connect Biopharma Holdings position peaked at $3.59M in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on BML Capital Management's 13F filing for Q1 2026, filed 6 May 2026.